| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |